This page shows the latest Zoladex news and features for those working in and with pharma, biotech and healthcare.
expansion of a facility in Macclesfield intended to support high demand for prostate cancer drug Zoladex.
This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood
ongoing. A further $70m is also up for grabs should Zoladex (goserelin acetate implant) meet a series of sales-related milestones. ... It also ensure patients have continued access to Zoladex, with TerSera's dedicated focus helping to expand the
AZ saw sales fall across much of its oncology brands, with a 4% decline for its biggest cancer seller Zoladex (goserelin) for certain breast cancers with revenue just shy of being
The new building in Macclesfield, Cheshire will focus on the production of prostate cancer treatment Zoladex (gosrelin), which has annual sales of around $1bn. ... Zoladex has been manufactured in Macclesfield for more than 25 years and AZ said the new
They are sold as Lupron (manufactured by Abbott), Zoladex (AstraZeneca), Trelstar (Watson), Viadur (Alza), and Eligard (sanofi-aventis) as well as under several generic labels.
More from news
Approximately 2 fully matching, plus 14 partially matching documents found.
First approved in North America in 1989, Zoladex sales in 2016 were $69m in the US and Canada and $816m globally. ... Licence. 358. AstraZeneca/ TerSera Therapeutics. Zoladex, goserelin acetate implant for prostate, breast cancer, benign gynaecological
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...